Sunshine Biopharma (SBFM) Asset Utilization Ratio (2016 - 2025)
Historic Asset Utilization Ratio for Sunshine Biopharma (SBFM) over the last 9 years, with Q3 2025 value amounting to 1.18.
- Sunshine Biopharma's Asset Utilization Ratio rose 593.34% to 1.18 in Q3 2025 from the same period last year, while for Sep 2025 it was 1.18, marking a year-over-year increase of 593.34%. This contributed to the annual value of 1.2 for FY2024, which is 4145.9% up from last year.
- As of Q3 2025, Sunshine Biopharma's Asset Utilization Ratio stood at 1.18, which was up 593.34% from 1.19 recorded in Q2 2025.
- In the past 5 years, Sunshine Biopharma's Asset Utilization Ratio registered a high of 1.21 during Q1 2025, and its lowest value of 0.01 during Q3 2022.
- Moreover, its 5-year median value for Asset Utilization Ratio was 0.52 (2023), whereas its average is 0.56.
- In the last 5 years, Sunshine Biopharma's Asset Utilization Ratio crashed by 8506.44% in 2022 and then surged by 602784.19% in 2023.
- Over the past 5 years, Sunshine Biopharma's Asset Utilization Ratio (Quarter) stood at 0.1 in 2021, then grew by 27.67% to 0.12 in 2022, then soared by 606.75% to 0.88 in 2023, then soared by 31.33% to 1.15 in 2024, then grew by 2.24% to 1.18 in 2025.
- Its Asset Utilization Ratio was 1.18 in Q3 2025, compared to 1.19 in Q2 2025 and 1.21 in Q1 2025.